A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia
References
- 1Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med. 2015; 372(3): 249–63. DOI: 10.1056/NEJMra1311488
- 2Hughes AJ, Colosimo C, Kleedorfer B, et al. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry. 1992; 55(11): 1009–13. DOI: 10.1136/jnnp.55.11.1009
- 3Boesch SM, Wenning GK, Ransmayr G, Poewe W. Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2002; 72(3): 300–3. DOI: 10.1136/jnnp.72.3.300
- 4Tan EK, Chan LL. ‘Diphasic’ levodopa-induced chorea in multiple system atrophy. Int J Clin Pract. 2010; 64(1): 126–8. DOI: 10.1111/j.1742-1241.2006.00889.x
- 5Tossici-Bolt L, Hoffmann SM, Kemp PM, et al. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging. 2006; 33(12): 1491–9. DOI: 10.1007/s00259-006-0155-x
- 6Kahraman D, Eggers C, Schicha H, et al. Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson’s disease. J Neurol. 2012; 259(2): 251–60. DOI: 10.1007/s00415-011-6163-1
- 7Hong JY, Oh JS, Lee I, et al. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease. Neurology. 2014; 82(18): 1597–604. DOI: 10.1212/WNL.0000000000000385
- 8Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008; 71(9): 670–6. DOI: 10.1212/01.wnl.0000324625.00404.15
- 9Munoz E, Iranzo A, Rauek S, et al. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C). J Neurol. 2011; 258(12): 2248–53. DOI: 10.1007/s00415-011-6108-8
- 10Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain. 2004; 127(Pt 12): 2657–71. DOI: 10.1093/brain/awh303
- 11Mosharov EV, Borgkvist A, Sulzer D. Presynaptic effects of levodopa and their possible role in dyskinesia. Mov Disord. 2015; 30(1): 45–53. DOI: 10.1002/mds.26103
- 12Latorre A, Bloise MC, Colosimo C, et al. Dyskinesias and motor symptoms onset in Parkinson disease. Parkinsonism Relat Disord. 2014; 20(12): 1427–9. DOI: 10.1016/j.parkreldis.2014.10.002
- 13Roussakis AA, Politis M, Towey D, Piccini P. Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias. Neurology. 2016; 86(12): 1152–8. DOI: 10.1212/WNL.0000000000002494
- 14Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997; 12(2): 133–47. DOI: 10.1002/mds.870120203
- 15Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997; 145(2): 205–11. DOI: 10.1016/S0022-510X(96)00231-6
- 16Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006; 66(11): 1717–20. DOI: 10.1212/01.wnl.0000219042.60538.92
- 17Wenning GK, Tison F, Seppi K, et al. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord. 2004; 19(12): 1391–402. DOI: 10.1002/mds.20255
DOI: https://doi.org/10.5334/tohm.58 | Journal eISSN: 2160-8288
Language: English
Submitted on: Aug 9, 2020
Accepted on: Apr 18, 2020
Published on: Jun 15, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2020 Shin-ichi Ueno, Genko Oyama, Kazuaki Kanai, Taku Hatano, Yasushi Shimo, Nobutaka Hattori, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.